chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up at approximately 4:00 am with headache and severe dizziness.  It was so bad it forced me to go to Emergency Room at the Medical Center 3/7/21.  They checked my eyes that were bouncing back and forth, gave me IV, did an EKG.  Prescribed Meclizine 25 mg for the dizziness, three times a day.  Absolutely no help.  Went to Primary Care Physician, and he thought it might be an inner ear infection and gave me a prescription for progressive Steroid Treatment.  No help.  Got appointment for 4/9/21 with Ear, Nose and Throat specialist.  At the same appointment was sent to see, an Audiologist in the same building.  The two doctors determined it was not an inner ear problem.  I was then advised to get a Cat Scan of my Brain and see my cardiologist.    I am now in my 6th week of major dizziness which has affected all aspects of my life.
I started out with allergy like symptoms. Runny nose, itchy and watery eyes, scratchy throat. When I woke up the next morning, I felt achy. Didn?t have a cough yet but had some difficulty breathing. Allergy symptoms were still there. Much more of a sore throat but the biggest change was the strong aches and pains that I woke up with. It didn?t prevent me from doing much, and I was able to function at least. But it prompted me to take an at home test and came back positive quickly. I called my doctor with the 24-hour nurse line. Because of my asthma and my BMI, they prescribed me Paxlovid and I started that immediately on Monday, May 9 for a 5 day course. I isolated from my family and I took the medicine and by Thursday, my symptoms had disappeared. Didn?t have tightness in my chest or the cough. No itchy eyes or allergy symptoms. By Sunday I was symptom free and tested negative on an at home test. I would say for about 2 weeks after, I felt tired. A little lethargic and then after about 2 weeks I felt completely normal like I did before.
31Dec 0300 Extreme body ache, unable to move left arm 31Dec Body aches, chills, swelling of injection site 31 Dec 1700 fever 102.1, injection site welt hard, painful, hot with 3 inch diameter, severe body aches and chills. Alternating Tylenol and Motrin begins fever lowers to 99 01Jan severe body aches and chills 01Jan 1130 fever of 101.1 while continuing alternating Tylenol and Motrin administration from previous day.  02Jan no fever, mild body aches, minor swelling and tenderness of injection site.
has tested positive shortly after; has tested positive shortly after; This is a spontaneous report from a contactable pharmacist. A patient of unknown age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The pharmacist asked for recommendation for the 2nd dose of the patient who had received the 1st dose but had tested positive shortly after. The outcome of the events was unknown.  information on the LOT/Batch number has been requested.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported event cannot be excluded.
Patient presented to the hospital on 9/13/21 complaining of 2 weeks of SOB and chest pain. She tested positive for COVID on 9/13/21 and her chest X-ray showed atypical pneumonitis, likely COVID-19. The patient is not hypoxic.
had some odd / weird feelings (painful - on and off) in my chest / heart; had some odd / weird feelings (painful - on and off) in my chest / heart; get aches and pains in my joints (feet, ankles, knees)/Left elbow was sore / painful; get aches and pains in my joints (feet, ankles, knees); neck is still stiff; got worse after I got the second shot; not feeling so great since he got the shots/feel like I'm 80 years old; This is a spontaneous report from a contactable consumer (patient).  A 57-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 13Apr2021 (Batch/Lot Number: EW0158) age at vaccination of 57-years-old, as single dose, for covid-19 immunisation.  Medical history was none. No known allergies. The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 23Mar2021 (Batch/Lot Number: ER2613), as single dose, for covid-19 immunisation and experienced stiff neck, pain in elbow, feeling unwell. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced stiff neck on left side (the side he got shots on) after getting the first shot, it started to go away after 2 weeks, and then it got worse after he got the second shot. It's not as bad as before, but neck was still stiff. Left elbow was sore/painful ever since he got the shots. Also, he had some odd / weird feelings (painful - on and off) in chest/heart area for a few weeks after the second shot, but they went away eventually. It's been a few months of generally not feeling so great since he got the shots. Example, he get aches and pains in joints (feet, ankles, knees) and he felt like he is 80 years old - especially in the morning. He had never had that before. It was unknown if patient had COVID prior vaccination or if was tested for COVID post vaccination. No treatments were given for the events. The patient was not recovered from the events.
I have stroke like symptoms-left side; This is a spontaneous report received from a contactable reporter (Consumer) from medical information team, Program ID: The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "covid-19" (unspecified if ongoing), notes: Patient was vaccinated while patient was infected with covid-19. The patient's concomitant medications were not reported. The following information was reported: PSEUDOSTROKE (medically significant), outcome "unknown", described as "stroke like symptoms-left side". The patient underwent the following laboratory tests and procedures: Computerised tomogram: No stroke.  Clinical course: Patient was vaccinated while patient was infected with covid-19. As a result, patient had stroke like symptoms-left side. CAT scan revealved no stroke.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pain at injection site mild, nausea and vomiting, body aches, migraines,fatigue
Patient given a Pfizer vaccine indicated for 12 and older. Patient is 8 years old.
Mom states the day after his last imms (11-22-13) infant broke out in hives to face, body, extremity. No wheezing. Baby did not seem bothered. Hives lasted several days and resolved on their own.
Client received PNEUMOVAX that had been out of the 2 degree - 8 degree C range for approx 50-60 min. Temperature in the storage cooler ranged from 9-10 degree C. Time frame 9a-10AM.
Pain and severe stiffness in neck.  Unable to turn my head at all for initial 48 hours.  Symptoms have reduced but have still not subsided 2 months later.
No adverse event; The patient explains that she is immunocompromised. and took she had a Moderna booster On 14Oct2021; This spontaneous case was reported by a patient and describes the occurrence of ACCIDENTAL UNDERDOSE (The patient explains that she is immunocompromised. and took she had a Moderna booster On 14Oct2021) and NO ADVERSE EVENT (No adverse event) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002F21A and 031B21A) for COVID-19 prophylaxis.     Concurrent medical conditions included Diabetes mellitus (Patient has been a diabetic for past 50 years) and Immunocompromised.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL UNDERDOSE (The patient explains that she is immunocompromised. and took she had a Moderna booster On 14Oct2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (The patient explains that she is immunocompromised. and took she had a Moderna booster On 14Oct2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant medication was reported.  No treatment information was provided.   This case was linked to MOD-2022-623976 (Patient Link).
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 09-JAN-2015, the patient was vaccinated with an improperly stored dose of VAQTA 25 U/0.5ml (lot # J011712, expiration date 21-SEP-2015). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 48, 32 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
Initial unsolicited misuse report received from a non-health care professional on 13 December 2016. It was reported that, a nurse while giving the intradermal dose of FLUZONE Intradermal (lot number, expiration date, dose, dose in series were not reported) to patient, patient jumped. The patient's medical history and concomitant medications were not reported. The nurse believed that, needle went through glove and had a scratch. It was a case of Occupational exposure to product. Patient event scratch outcome was not reported. No adverse event reported. List of the documents held by sender: none.
Seen 9/25 in clinic with rash.  Culture sent.  Positive Varicella (post vaccine 10/25/07).
Patient reported developing shingles 7 days after vaccine administration.  He has been treated with anti-viral ever since.  He reported forehead and near the eye were areas affected.
This study case was received from the investigator on 27 August 2012. A male subject with no reported past medical history had received ACAM2000 (lot number, route, site and date of administration not reported) and an unspecified amount of time later was found to have on 23 September 2009 an elevated Troponin, central laboratory level of 0.17 ng/ml. The subject had a rapid Troponin I level on 23 September 2009 that was within normal limits (negative). No ECG was performed. No other reported visits, no chest x-ray, no echo and no labs. The subject had no concomitant medications. No further information was available at the time of the report. The subject's outcome was not reported. According to the investigator, the event of elevated Troponin was considered an other important event and was possibly related to vaccination. Per the Investigator, this represents a case of potential myopericarditis and was referred to the study's adjudication committee for assessment. Documents held by sender: none.
Parents noted rash all over body, low grade fever. ER MD thought viral. No other symptoms. Reported per protocol.
At time indicated, had joint pain, achiness in bones, chills (t-max of 99.3) and fatigue.  These lasted for 2 days and the symptoms improved however I am still having the joint pain and achiness (left lower extremity worse than right) and it is status post 1 week from injection
Information has been received from a consumer concerning her now 5 year old son with OMNICEF allergy and a history of bronchiolitis at 5 weeks of age who was vaccinated with a dose of MMR II at around 1 year of age (in approximately October 2004). Concomitant therapy included vitamins (unspecified). The patient was later diagnosed with autism at around 2 years of age (in approximately October 2005). At time of reporting, the patient did not recover. The patient sought unspecified medical attention. Upon internal review, autism was determined to be an other important medical event. This is one of several reports received from the same source. Additional information has been requested.
Left Bell's Palsy; Facial distortion; Memory issues, forgetting names/events/dates.; Inappropriate schedule of vaccine administered; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 76-year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 11May2021 16:00 (Lot number: EN6205) at the age of 76-years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing); "Depression" (unspecified if ongoing); and "Sleep Apnea" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL TARTRATE; LEVOTHYROXINE; ATORVASTATIN; TAMSULOSIN; CLONAZEPAM; ALLOPURINOL; METFORMIN. Vaccination history included: Bnt162b2 (Lot number=EN6200, dose administrator route: Intramuscular, dose administration date: 19Feb2021, dose administration time: 4:00PM, dose number: 1, vaccine location: Left Arm), when the patient was 75-years-old, for Covid-19 Immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The following information was reported: BELL'S PALSY (disability) with onset 01Aug2021, outcome "not recovered", described as "Left Bell's Palsy"; FACIAL DISCOMFORT (disability) with onset 01Aug2021, outcome "not recovered", described as "Facial distortion"; MEMORY IMPAIRMENT (disability) with onset 01Aug2021, outcome "not recovered", described as "Memory issues, forgetting names/events/dates."; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 11May2021 16:00, outcome "unknown", described as "Inappropriate schedule of vaccine administered". The events "left bell's palsy", "facial distortion" and "memory issues, forgetting names/events/dates" were evaluated at the physician office visit. Therapeutic measures taken as a result of bell's palsy, facial discomfort, memory impairment included "IFC 8MV". It was also reported that since the vaccination, the patient had not been tested for COVID-19.; Sender's Comments: Based on temporal association , a causal association between BNT162B2 and the reported events Bells Palsy, facial Paralysis, Memory impairment  cannot be completely excluded   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators.
fever overnight (Fri/Sat) 102 F  Rash on chest, back and both arms.
This spontaneous report was received from a registered pharmacist concerning an approximately 65 year old female patient. On 03-SEP-2013, the patient was vaccinated with 0.65 milliliter (ml) of ZOSTAVAX (lot number and expiry date were reproted as J003796 and 28-JUN-2014 respectively), subcutaneously. No concomitant therapy was reported. Approximately on an unknown date in September 2013, the patient experienced as rash around the ZOSTAVAX injection site which was the size of a quarter and did not appear real red. The rash, around the ZOSTAVAX injection site was tender and warm to the touch. The patient sought medical attention (saw the pharmacist on 07-SEP-2013). No treatment was provided. It was unspecified if any lab tests were performed. Outcome of the events was unknown. The relatedness for the events was unknown for ZOSTAVAX. This is one of the two reports from the same source. Additional information has been requested.
Vasovagal episode approximately 5 minutes after the vaccine was administered. Unresponsive for < 1 minute, breathing normal, diaphoretic and pale. Resolved with lying down, elevating legs, fluids. vital signs, oximetry, and glucose normal throughout
Information has been received from a nurse concerning a 13 year old female who on 19-Nov-2007 was vaccinated with her first dose of Gardasil (Lot #656371/0181U).  Concomitant therapy included influenza virus vaccine (unspecified).  On 19-Nov-2007 the patient fainted.  Subsequently, the patient recovered from fainting.  Additional information has been requested. Information has been received from a nurse concerning a 13 year old female who on 19-NOV-2007 was vaccinated intramuscularly in the right deltoid with her first dose of HPV (lot # 656371/0181U).  On 19-NOV-2007 the patient fainted within 2 minutes of receiving the HPV vaccine. Follow up information reported that after receiving both immunizations, the patient suddenly said "I can't see" and collapsed to the floor froma standing position. She was unconscious for 5 - 10 seconds and then opened her eyes and asked what happened. The nurse kept her on the floor and gave her soda to drink. The patient was weak, shaky, pale, diaphoretic, and nauseous for approximately 10 -to 15 minuts. On 19-NOV-2007, the patient experienced a full recovery from fainting. And being weak, pale, diaphoretic, shak, and nauseous.
Received Zostavax on 10/19/2016 - Woke up Thursday morning with redness and heat in localized area with mild welting. Redness continued to spread down arm over the next two days. Still hot today (10/22/16). Burning/stinging sensation in localized area. No pain in shoulder/fingers/rest of arm. Stated seems better today (10/22/2016) than yesterday.
On 7/28, two day after the pt received the ZOSTAVAX vaccine, she came in complaining of swelling, redness and tenderness at the injection site. She tried an icepack and BENADRYL, but it became worse, so she went to the ER to have it looked at.
Headache, Myalgia, pain at injection site, fatigue, irritability Narrative:
Rapid heart which she thinks was Atrial fibrillation; This spontaneous case was reported by a nurse and describes the occurrence of HEART RATE INCREASED (Rapid heart which she thinks was Atrial fibrillation) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEART RATE INCREASED (Rapid heart which she thinks was Atrial fibrillation). At the time of the report, HEART RATE INCREASED (Rapid heart which she thinks was Atrial fibrillation) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Heart rate: increased (High) Increased.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Oct-2021: Follow up received contains Non-Significant followup:Email Address Verified
Pt lethargic not verbally responsive upon first attempt of questioning. Pt responded to second question that he "felt weak" BP: 120/80 P.64
CC- atypical myositis following FluMist. 33 year old previously healthy man presented with a 3 day history of bilateral forearm pain and progressive hand and wrist weakness. He received FluMist (MedImmune on 10/11/11. Lot #501111P, Exp. 12/1/11) 10 days prior to the onset of symptoms and was well at that time. He had a concurrent viral URI without a fever at time of arm symptoms. No recent medications or exposures. He works in a hospital as a pediatric neurology resident. Symptoms began with soreness in bilateral proximal forearms which intensified over the following 2-3 days. These myalgias were exacerbated by use of the associated muscles. There was also soreness of the upper arms and legs, but this was considerably milder. Forearms also became progressively swollen and there was a faint reticular rash over the forearms and trunk. He developed progressive weakness of his bilateral intrinsic hand and wrist muscles, with flexors more affected than extensors. Right and left were equally involved. There was no weakness in any other muscle groups. Pain was severe enough to interrupt sleep and combined with the weakness inhibited regular activities of writing, typing, gripping utensils. Muscles of the forearm were tender to palpation, but not more proximally or in the lower limbs. The weakness and pain both peaked around day 3. Ibuprofen was mildly effective at treating the pain. There were no sensory changes and reflexes were preserved on exam. No lymphadenopathy or pharyngitis findings on exam.  No joint findings. Lungs clear. General PE otherwise normal. A Medrol dose pack was initiated for treatment of myositis. Symptoms gradually improved over the following 3-5 days with strength returning to normal and some persistent mild myalgias in the proximal forearms. Back to baseline on 10/31/11.
On 3/26, woke with large hives covering entire body, swollen eyes, swollen and numb lips and itchy. No SOB. Seen at ER and given IV Benadryl, IV Pepcid and IV prednisone. Rx for oral prednisone, Benadryl and Tagamet. 3/27, improved, but on 3/28, hives flared. No SOB. Seen by com. personal physician and given Solu-Medrol, IM, and increased oral dose of prednisone. On 3/29, seen by allergist and dx'd with possible Anthrax vaccine adverse event. Continued 3 week course of prednisone with steadily decreasing symptoms. Completely recovered.  Follow up 06/05/2000: "Patient recovered from adverse event."
aches; severe dull funny headache; Very Sleepy; very fatigued; just not feeling himself; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches), HEADACHE (severe dull funny headache), SOMNOLENCE (Very Sleepy), FATIGUE (very fatigued) and FEELING ABNORMAL (just not feeling himself) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN (aches), HEADACHE (severe dull funny headache), SOMNOLENCE (Very Sleepy), FATIGUE (very fatigued) and FEELING ABNORMAL (just not feeling himself). At the time of the report, PAIN (aches), HEADACHE (severe dull funny headache), SOMNOLENCE (Very Sleepy), FATIGUE (very fatigued) and FEELING ABNORMAL (just not feeling himself) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Concomitant medication were provided No treatment were provided
2-27-21 Heart pain, transported to ER 2x in 2 days. Within 2 days, her Liver and Kidney function failed. and  Acute Hypoxic Respiratory Failure  and Cardiogenic Shock were listed as cause of death on 3-3-21
After 8 hours nothing but sore arm at injection site which I could relieve most soreness by moving arm a lot.  At 10 hours I was very tired and went to bed early (8pm vice 10pm normal bedtime).  At 13 hours I got up to take 1st dose of tylenol and was very chilled, shivering so violently I could not open the vacuum packed seal.  Day 2 I had low grade, 100.5, fever with chills, sweats back and forth. Today, Day 3 I am feeling 100% after sweating out fever overnight.
late menstrual cycle- still has not started. Last cycle date Jan 16, 2022; cycle expected February 18, 2022.
Date; 10,13,08 - about 12:PM child, Fever, No Food, not hungry on Oct. 15,08 No treatment - slept most all day.